NovellusDx's Series B - II Round

NovellusDx raised a round of funding on June 21, 2016. Investors include OrbiMed Advisors.

NovellusDx, founded in 2012, identifies tumor specific driver mutations, however unlike sequencing-based tests, the company's technology is based on a functional assay that detects disregulated transl…

Articles about NovellusDx's Series B - II Round: